14/07/2006
ReGen Therapeutics Plc (‘ReGen’) is aware of recent market uncertainty in relation to its expected revenues for the current financial year.
ReGen confirms that Guildford Clinical Pharmacology Unit Limited (‘GCPUL’) is the only company in the ReGen group which currently has revenues. The current order book is around £870,000, with ReGen being the largest single customer. Accordingly, based on the current order book, ReGen’s expectation of external revenue from GCPUL for the current financial year is in the region of £550,000 to £600,000. In addition, GCPUL continues in its discussions in relation to a number of potential orders.
Further information:
Andrew Marshall
Greycoat Communications
Tel: 020 7960 6007
Mobile: 07785 297111